Effects ofPelargonium sidoidesextract vs roxithromycin on chemokine levels in nasal secretions of patients with uncomplicated acute rhinosinusitis
Open Access
- 21 December 2020
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 6 (1), 25-33
- https://doi.org/10.1002/lio2.514
Abstract
Background Previous investigations suggest the use of extract from the roots of Pelargonium sidoides (EPs 7630) for the therapy of uncomplicated rhinosinusitis. The aim of this prospective study was to compare the effects of herbal drug EPs 7630 and antibiotic roxithromycin on chemokine production in nasal mucosa and clinical parameters in patients with uncomplicated acute bacterial rhinosinusitis (ABRS). Methods Seventy‐eight ABRS patients were divided into 26 patients receiving EPs 7630 tablets, 3 × 20 mg/day per os (group 1), 26 patients receiving roxithromycin tablets, 2 × 150 mg/day per os (group 2), both for 10 days, and 26 patients who received no therapy (Control group). We measured chemokine levels in nasal secretions by flow cytometry and assessed clinical parameters on day 0 and day 10 of investigation. Results EPs 7630 increased concentrations of MCP‐1 (P = .001) and IP‐10 (P = .049) and decreased levels of MIP‐1α (P < .001), ENA‐78 (P < .001), and IL‐8 (P < .001). Roxithromycin increased levels of IP‐10 (P = .049) and decreased levels of MCP‐1 (P < .001), MIP‐1α (P < .016), ENA‐78 (P < .001), and IL‐8 (P < .001). Comparison of the non‐treated patients' group with groups 1 and 2 revealed significant improvement of all clinical parameters in treated patients (P < .001), but therapy with roxithromycin resulted in better improvement in nasal symptoms and endoscopic findings than therapy with EPs 7630. Conclusion Our results suggest the presence of similar modulatory effects of both therapies on production of chemokines that regulate the function of neutrophils and monocytes in nasal mucosa. Roxithromycin shows better clinical efficacy than EPs 7630 in patients with uncomplicated ABRS. Level of Evidence 1b.Keywords
This publication has 23 references indexed in Scilit:
- Clinical Practice Guideline (Update): Adult SinusitisOtolaryngology -- Head and Neck Surgery, 2015
- Pelargonium sidoides extract for treating acute respiratory tract infectionsEmergencias, 2013
- Role of antibiotics in sinusitisCurrent Opinion in Infectious Diseases, 2012
- Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion
Pharmaceuticals, 2011
- Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: Modulation of secretory IgA, IL-6 and IL-15Phytomedicine, 2011
- In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630Phytomedicine, 2007
- Nasal biomarker profiles in acute and chronic rhinosinusitisClinical & Experimental Allergy, 2005
- Macrophage inflammatory protein-1Cytokine & Growth Factor Reviews, 2002
- IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and TraffickingThe Journal of Immunology, 2002
- Acute Sinusitis: A Histopathological and Immunohistochemical StudyThe Laryngoscope, 2000